This article is more than 5 years old. Information may no longer be current.
Healio Minute Friday, Jan. 24, 2014 Edition: Cognitive decline redefined, psoriasis boosts type 2 diabetes risk, FDA speeds advisory panel nominations
What just happened in medicine and why do you care?
Click Here to Manage Email Alerts
Simulations of lifelong brain experience challenge definition of cognitive decline
Healio.com/Geriatric Medicine: Except in the case of neurological diseases where there is evidence of pathology, there is no neurobiological evidence for any declines in the processing capacities of healthy older adults, says researcher. Read more.
Psoriasis patients at increased risk for developing type 2 diabetes
Healio.com/Dermatology: The risk was modulated by the severity of psoriasis, comorbidites and concomitant medication, but physicians should be aware of the potential link with type 2 diabetes and concomitant medication, say researchers. Read more.
FDA launches advisory committee membership nomination portal
Healio.com: System will securely store all applicant information and enable the FDA to develop metrics for assessing the entire applicant pool to identify qualified candidates. Read more.
Impaired self-awareness linked to cocaine dependence
Healio.com/Psychiatry: Results raise possibility that a specific cocaine use disorder subgroup might benefit from the therapeutic interventions directed at enhancing the neuropsychological mechanisms underlying insight and self-awareness. Read more.
Adverse event rate declined among patients hospitalized for MI, congestive HF
Healio.com/Cardiology: Although results suggest that national efforts focused on patient safety have made some inroads, the lack of across-the-board reductions is disappointing, say researchers. Read more.